It is an endogenous peptide-copper complex identified in biological systems
Why people use it: The KPV peptide has gained traction in gut health circles, where people dealing with inflammatory bowel conditions (like Crohns disease or irritable bowel disease) want alternatives to steroids or other biologic medications and are looking for other ways to calm inflammation and support gut healing
(2013): Foundation Study The seminal study by McCoy and colleagues published in 2013 tested Dihexa in cognitive impairment models
The current framing places GHK-Cu in a long-running expansion-era position: continued mechanistic and translational research continues to appear, but with no near-term drug-approval prospect under the current regulatory framing
Primary goals: Skin texture and firmness, collagen synthesis, hair follicle support, tissue repair, inflammation reduction
TB-500: Common range: 25 mg weekly, split into 2 doses